Abstract
Background/Aim
Cardiotoxicity resulting in heart failure is a devastating outcome of cancer therapy. It is possible that a patient may survive cancer only to develop heart failure (HF), which ultimately has a higher mortality rate. The aim of this project was to a profile of the characteristics of at risk patients with cancer treatment induced heart failure.
Cardiotoxicity resulting in heart failure is a devastating outcome of cancer therapy. It is possible that a patient may survive cancer only to develop heart failure (HF), which ultimately has a higher mortality rate. The aim of this project was to a profile of the characteristics of at risk patients with cancer treatment induced heart failure.
Original language | English |
---|---|
Pages (from-to) | S99-S99 |
Number of pages | 1 |
Journal | JOURNAL OF CARDIAC FAILURE |
Volume | 20 |
Issue number | 8 |
DOIs | |
Publication status | Published - 2014 |
Event | 18th Annual Scientific Meeting, Heart Failure Society of America - Duration: 14 Sept 2014 → … |
Keywords
- heart failure
- cancer therapy
- chemotherapy